CME Presentations
DME
Presentations
Diabetic Macular Edema: How Frontline Providers Can Become Instrumental in Enhancing Access to Treatment for Every Patient
Speakers: Pamela Lowe, O.D, F.A.A.O, Diplomat ABO, Director/PresidentNita Sinha, OD, MPH, Director of Public HealthRishi P. Singh, MD, Staff SurgeonSerena Valentine, MBA-HCM, Executive Director Duration: 60 minutes
Presented on: October 4, 2022
Emerging Agents, Devices, and Treatment Regimens to Provide Patient-centered Care in Diabetic Macular Edema
Speakers: Caroline Baumal, MD, Professor of OphthalmologyRishi P. Singh, MD, Staff Surgeon Duration: 60 minutes
Presented on: November 1, 2022
Speakers
Pamela Lowe, O.D, F.A.A.O, Diplomat ABO
Pamela Lowe, O.D, F.A.A.O, Diplomat ABO
Director/President
Pamela Lowe, O.D., F.A.A.O., Diplomat ABO, is currently Director/President of Professional Eye Care Center, Incorporated, a private practice she founded in 1992 in Chicago. Dr. Lowe is active in organized optometry and is a Past President of the Illinois Optometric Association. She was awarded Illinois Young Optometrist of the Year in 1995 and Optometrist of the Year in 2006. Dr. Lowe serves as Vision Source Medical Director in Chicagoland, where she is an administrator for over sixty independent private practice locations. She has lectured and authored on many topics including retinal disease, cataract extraction, and laser vision correction. Furthermore, Dr. Lowe currently serves as Chair of the AOA Strategic Communications Committee.
Nita Sinha, OD, MPH
Nita Sinha, OD, MPH
Director of Public Health
Nita Sinha, OD, MPH, is the current Director of Public Health at Prevent Blindness since December 2009. At Prevent Blindness, Nita has led professional and public education around vision and eye health through annual summits, educational toolkits, awareness campaigns, and webinars. She staffs the organization’s scientific committee and has previously worked on federal grants. Before joining Prevent Blindness, Nita worked at the American Academy of Pediatrics on the Healthy Tomorrows Partnership for Children Program providing technical assistance to federally funded maternal and child health programs. Prior to then, she was a Program Manager at Helen Keller International working on eye health programs in the United States, Latin America, Africa, and Asia.Rishi P. Singh, MD
Rishi P. Singh, MD
Staff Surgeon
Rishi Singh, MD, is a staff surgeon at the Cole Eye Institute, Cleveland Clinic and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland, Ohio. Also, he serves as the medical director of informatics at the Cleveland Clinic. He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy and age-related macular degeneration. Dr. Singh has authored more than 200 peer reviewed publications and serves as the principal investigator of numerous clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists. Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award.
Serena Valentine, MBA-HCM
Serena Valentine, MBA-HCM
Executive Director
Ms. Serena Valentine, MBA-HCM, is the Executive Director of the CORE Initiative, a health and wellness education nonprofit organization in Houston, Texas; the organization works to make a difference in society through providing resources to all citizens and preparing all generations for success. Ms. Valentine is living with Type 2 diabetes and works as a diabetes peer educator with Cities Changing Diabetes, a global initiative that is managed by Novo Nordisk. In addition to her role at the CORE Initiative and Cities Changing Diabetes, Ms. Valentine works with Prevent Blindness to promote eye health and bring awareness to the connection between diabetes & vision loss.
Caroline Baumal, MD
Caroline Baumal, MD
Professor of Ophthalmology
Caroline Baumal, MD, is a Professor of Ophthalmology, Co-Director of the Retina Service, and Co- Director of the medical retina fellowship at New England Eye Center, Tufts Medical Center in Boston. She specializes in medical and surgical diseases of the retina and vitreous. Dr. Baumal’s research interests include novel retinal imaging and drug development, which are continuations from her research with the prototype OCT and working with drug implants and photodynamic therapy. Her clinical interests include age-related macular degeneration, diabetic retinopathy, retinal circulatory disorders, complex vitreoretinal surgery, and retinopathy of prematurity. Dr. Baumal has received multiple awards from many societies and was awarded the Lifetime Achievement award from the Vit-Buckle Society.
CME Information
Emerging Agents, Devices, and Treatment Regimens to Provide Patient-centered Care in Diabetic Macular EdemaJointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC, working in collaboration with Prevent BlindnessACKNOWLEDGEMENT
Supported by an educational grant from Genentech, a member of the Roche Group.TUITION
Complimentary
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.DATE OF LIVE ACTIVTY
Tuesday, November 1, 2022 from 6:00 – 7:00pm ETLIVE CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.DATE OF ENDURING MATERIAL RELEASE/EXPIRATION
The enduring material will be available from November 1, 2022 to November 1, 2023.ENDURING CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:- Recognize the burden that DME and the need for frequent monitoring and current anti-VEGF treatments impose on patients and caregivers, with emphasis on impacts on people from marginalized racial and ethnic groups
- Describe strategies to implement a team approach to DME care, working with the optometrist and other care providers at the frontline of diabetes care to enhance screening for DME, and with the patient / caregiver to plan effective treatment regimens that help enhance adherence
- Summarize the MOAs and safety and efficacy data for new and emerging therapeutic options for DME, with a focus on dual VEGF/Ang 2 antagonists
- Recognize how emerging agents and delivery systems may offer treatment alternatives to patients that could reduce the need for frequent injections, while maintaining or improving visual acuity
TARGET AUDIENCE
The intended audience for this activity are ophthalmologists, optometrists, and specialty NPs and nurses who diagnose and treat AMD.ESTIMATED TIME TO COMPLETE
This activity should take approximately 1 hour to complete.METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship Caroline Baumal, MD
Professor of Ophthalmology
New England Eye Center
Tufts MedicineConsultant/Advisory Board: Apellis, Genentech, Ocuphire, Opthea, Ora, Regeneron Rishi P. Singh, MD
Staff Physician, Cleveland Clinic Florida
Professor of Ophthalmology, Case Western Reserve University
President, Cleveland Clinic Martin HospitalConsultant/Advisory Board: Alcon, Apellis, Asclepix, Bausch and Lomb, Genentech, Gyroscope, Novartis, Regeneron
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner Reported Financial Relationship Carole Drexel
Medical Director
PlatformQ Health Education, LLCNone Eve Wilson
Medical Director
PlatformQ Health Education, LLCNone
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Jaimee Harris-Gold, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.
Technical Support: For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive.com at 1-877-394-1306 or at Support@ClinicalSeriesLive.
Diabetic Macular Edema: How Frontline Providers Can Become Instrumental in Enhancing Access to Treatment for Every PatientJointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC, working in collaboration with Prevent BlindnessACKNOWLEDGEMENT
Supported by an educational grant from Genentech, a member of the Roche Group.TUITION
Complimentary
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.DATE OF LIVE ACTIVTY
Tuesday, October 4, 2022 from 7:00 – 8:00pm ETLIVE CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.COUNCIL ON OPTOMETRIC PRACTITIONER EDUCATION (COPE) CREDIT STATEMENT – Interactive Distance Learning Course
This activity, COPE Activity Number 80627-TD is accredited by COPE for continuing education for optometrists. This course is COPE approved for 1 hour of CE credit. Course ID is 124673. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.DATE OF ENDURING MATERIAL RELEASE/EXPIRATION
The enduring material will be available from October 4, 2022 to November 1, 2023.ENDURING CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.COUNCIL ON OPTOMETRIC PRACTITIONER EDUCATION (COPE) CREDIT STATEMENT – Enduring Distance Learning Course
This activity, COPE Activity Number 80629-TD is accredited by COPE for continuing education for optometrists. This course is COPE approved for 1 hour of CE credit. Course ID is 124674. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:- Apply current evidence-based screening recommendations for DME
- Describe multidisciplinary approaches to help patients access eye examination for DME detection and wholistic diabetes care with a focus on strategies to improve access and care for under resourced communities
- Discuss the rationale and urgent need for optometrists to work collaboratively with ophthalmologists to confirm a diagnosis of DME early and facilitate access to treatment
- Recognize the promise of the growing pipeline for management of DME to maintain or improve visual acuity and reduce the need for frequent injection
TARGET AUDIENCE
The intended audience for this activity are optometrists, ophthalmologists, specialty NPs, and nurses who diagnose and treat DME.ESTIMATED TIME TO COMPLETE
This activity should take approximately 1 hour to complete.METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship Pamela A. Lowe, OD, FAAO, Dipl. ABO
Past Chair, AOA Contact Lens Cornea Section
Diplomate, American Board of Optometry
Vision Source Medical Director, Chicago
Director, Professional Eye Care Center, Inc.Employee/Owner: Professional Eye Care Center, Inc. Speakers Bureau/Honoraria for non-CME: Alcon, Maculogix Rishi P. Singh, MD
Staff Physician, Cleveland Clinic Florida
Professor of Ophthalmology, Case Western Reserve University
President, Cleveland Clinic Martin HospitalConsultant/Advisory Board: Alcon, Visible GenomicsConsultant/Advisory Board: Alcon, Apellis, Asclepix, Bausch and Lomb, Genentech, Gyroscope, Novartis, Regeneron Nita Patel Sinha
Director, Public Health
Prevent BlindnessNon-Mutual funds Stock Ownership/Stock Options: Abbvie, Biogen Serena Valentine, MBA-HCM
Executive Director at CORE initiative and Diabetes Peer Educator
Patient PresenterNothing to disclose
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner Reported Financial Relationship Carole Drexel
Medical Director
PlatformQ Health Education, LLCNone Eve Wilson
Medical Director
PlatformQ Health Education, LLCNone
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Jaimee Harris-Gold, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.
Technical Support: For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive.com at 1-877-394-1306 or at Support@ClinicalSeriesLive.
